This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moonen, C. T.W. Search for Related Content PubMed PubMed Citation Articles by Moonen, C. T.W. Related Collections Therapeutics and Targets Therapeutics and Targets: Experimental Therapeutics– Biologics Clinical Research Clinical Research: Imaging, Diagnosis, and Prognosis

Spatio-Temporal Control of Gene Expression and Cancer Treatment Using Magnetic Resonance Imaging–Guided Focused Ultrasound

Author's Affiliation: Laboratory for Molecular and Functional Imaging: From Physiology to Therapy, UMR 5231 Centre National de la Recherche Scientifique, Université "Victor Segalen" Bordeaux 2, Bordeaux, France

Requests for reprints: Chrit T.W. Moonen, UMR 5231, Imagerie Moléculaire et Fonctionnelle, Université "Victor Segalen" Bordeaux 2, 146 rue Leo Saignat, case 117, 33076 Bordeaux, France. Phone: 33-5-57-57-45-86; Fax: 33-5-57-57-45-97; E-mail: chrit.moonen{at}imf.u-bordeaux2.fr.

Abstract

Local temperature elevation may be used for tumor ablation, gene expression, drug activation, and gene and/or drug delivery. High-intensity focused ultrasound (HIFU) is the only clinically viable technology that can be used to achieve a local temperature increase deep inside the human body in a noninvasive way. Magnetic resonance imaging (MRI) guidance of the procedure allows in situ target definition and identification of nearby healthy tissue to be spared. In addition, MRI can be used to provide continuous temperature mapping during HIFU for spatial and temporal control of the heating procedure and prediction of the final lesion based on the received thermal dose. The primary purpose of the development of MRI-guided HIFU was to achieve safe noninvasive tissue ablation. The technique has been tested extensively in preclinical studies and is now accepted in the clinic for ablation of uterine fibroids. MRI-guided HIFU for ablation shows conceptual similarities with radiation therapy. However, thermal damage generally shows threshold-like behavior, with necrosis above the critical thermal dose and full recovery below. MRI-guided HIFU is being clinically evaluated in the cancer field. The technology also shows great promise for a variety of advanced therapeutic methods, such as gene therapy. MR-guided HIFU, together with the use of a temperature-sensitive promoter, provides local, physical, and spatio-temporal control of transgene expression. Specially designed contrast agents, together with the combined use of MRI and ultrasound, may be used for local gene and drug delivery.

This article has been cited by other articles:

				J. A. Poff, C. T. Allen, B. Traughber, A. Colunga, J. Xie, Z. Chen, B. J. Wood, C. Van Waes, K. C. P. Li, and V. Frenkel Pulsed High-Intensity Focused Ultrasound Enhances Apoptosis and Growth Inhibition of Squamous Cell Carcinoma Xenografts with Proteasome Inhibitor Bortezomib Radiology, August 1, 2008; 248(2): 485 - 491. [Abstract] [Full Text] [PDF]

				G. C. Prendergast Non-Invasive Imaging: Enhancing Preclinical Research and Evidence-Based Medicine Cancer Reviews Online Content, July 1, 2007; 2007(4): 7 - 7. [Full Text] [PDF]

				R. G. Blasberg Imaging Update: New Windows, New Views Clin. Cancer Res., June 15, 2007; 13(12): 3444 - 3448. [Full Text] [PDF]